ONYX Pharmaceuticals Inc. (ONXX) President & CEO N Anthony Coles sells 1,576 Shares

President & CEO of ONYX Pharmaceuticals Inc. (ONXX, Financial) N Anthony Coles sells 1,576 shares of ONXX on 04/20/2010 at an average price of $29.95 a share.

Onyx Pharmaceuticals Inc. has a market cap of $1.82 billion; its shares were traded at around $29.14 with a P/E ratio of 53 and P/S ratio of 7.3.

ONXX is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Edward Owens of Vanguard Health Care Fund, Jim Simons of Renaissance Technologies LLC, George Soros of Soros Fund Management LLC.

CEO Recent Trades:

  • Sell:: President & CEO N Anthony Coles sold 8,922 shares of ONXX stock on 04/01/2010 at the average price of 30.1, the price of the stock has decreased by 3.19% since.



CFO Recent Trades:

  • Sell:: CFO Matthew K Fust sold 1,919 shares of ONXX stock on 01/06/2010 at the average price of 29.6, the price of the stock has decreased by 1.55% since.



Directors and Officers Recent Trades:

  • Sell:: EVP and Chief Business Officer Laura Brege sold 12,500 shares of ONXX stock on 04/15/2010 at the average price of 30.4, the price of the stock has decreased by 4.14% since.

  • Sell:: VP, Corp. Communication/I.R. Julianna R Wood sold 1,698 shares of ONXX stock on 04/01/2010 at the average price of 30.12, the price of the stock has decreased by 3.25% since.

  • Sell:: SVP, Corporate Development Juergen Lasowski sold 739 shares of ONXX stock on 04/01/2010 at the average price of 30.1, the price of the stock has decreased by 3.19% since.

  • Sell:: EVP and Chief Business Officer Laura Brege sold 7,667 shares of ONXX stock on 04/01/2010 at the average price of 30.12, the price of the stock has decreased by 3.25% since.

  • Sell:: VP, Org Learning, Dvlpmnt & HR Judy A Batlin sold 494 shares of ONXX stock on 04/01/2010 at the average price of 30.1, the price of the stock has decreased by 3.19% since.